HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

Prof. Francisca Mutapi, a global health expert suggests 4 ways to end the dependence HEALTH | FRANCISCA MUTAPI | There’s been a global trend in the reduction of aid to Africa since 2018. Donors are ...

Providing feedback following point-of-care urine testing for tenofovir concentrations was associated with increased PrEP ...

A new study in Australia found that treating male partners can reduce BV reinfections, suggesting that BV may be sexually ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...

Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for ...

Scientists have got success with a new injection of HIV. Taking this injection once a year can reduce the risk of HIV ...

New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically ...

Measles is unlike other childhood viruses. In severe cases, it can cause pneumonia. About 1 in 1,000 patients develops encephalitis.

Incident HCV infection more than doubled among HIV-positive MSM with no history of injection drug use between 1995 and 2023.

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...